Sign In
Buy CCXI
$13.86
-0.140 (-1.00%)
At Close: Jul 31, 2026
Hedge Funds Are Betting On Progyny, Inc. (PGNY)
09:16pm, Tuesday, 07'th Apr 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
ChemoCentryx (CCXI) Upgraded to Buy: What Does It Mean for the Stock?
04:00pm, Tuesday, 07'th Apr 2020
ChemoCentryx (CCXI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ChemoCentryx (CCXI) Upgraded to Buy: What Does It Mean for the Stock?
04:00pm, Tuesday, 07'th Apr 2020
ChemoCentryx (CCXI) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Homology Medicines (FIXX) Gets a Buy Rating from Canaccord Genuity
10:04am, Monday, 06'th Apr 2020
In a report released today, Michelle Gilson from Canaccord Genuity reiterated a Buy rating on Homology Medicines (FIXX), with a price target of $37.00.
Homology Medicines (FIXX) Gets a Buy Rating from Canaccord Genuity
10:04am, Monday, 06'th Apr 2020
In a report released today,
Michelle Gilson
from Canaccord Genuity reiterated a
Buy
rating on Homology Medicines (
FIXX
–
Research Report
), with a price target of
$37.00
. The company’s shares cl
Canaccord Genuity Keeps Their Buy Rating on Homology Medicines (FIXX)
10:04am, Monday, 06'th Apr 2020
Canaccord Genuity analyst Michelle Gilson maintained a Buy rating on Homology Medicines (FIXX) on April 3 and set a price target of $37.00. The company's
Canaccord Genuity Keeps Their Buy Rating on Homology Medicines (FIXX)
10:04am, Monday, 06'th Apr 2020
Canaccord Genuity analyst Michelle Gilson maintained a Buy rating on Homology Medicines (FIXX – Research Report) on April 3 and
Brokers Issue Forecasts for ChemoCentryx Inc's Q1 2020 Earnings (NASDAQ:CCXI)
05:28am, Monday, 06'th Apr 2020
ChemoCentryx Inc (NASDAQ:CCXI) – Stock analysts at SVB Leerink issued their Q1 2020 earnings per share estimates for ChemoCentryx in a research report issued on Wednesday, April 1st. SVB Leerink ana
ChemoCentryx (NASDAQ:CCXI) Stock Rating Reaffirmed by SVB Leerink
05:50am, Sunday, 05'th Apr 2020
SVB Leerink reissued their outperform rating on shares of ChemoCentryx (NASDAQ:CCXI) in a research note issued to investors on Wednesday morning, Zacks.com reports. Several other analysts have also we
Victory Capital Management Inc. Has $392,000 Holdings in ChemoCentryx Inc (NASDAQ:CCXI)
08:02am, Saturday, 04'th Apr 2020
Victory Capital Management Inc. raised its position in ChemoCentryx Inc (NASDAQ:CCXI) by 45.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & E
ChemoCentryx Inc (NASDAQ:CCXI) Expected to Post Quarterly Sales of $8.90 Million
08:42am, Friday, 03'rd Apr 2020
Brokerages expect ChemoCentryx Inc (NASDAQ:CCXI) to announce $8.90 million in sales for the current fiscal quarter, according to Zacks Investment Research. Five analysts have made estimates for ChemoC
ChemoCentryx (NASDAQ:CCXI) Coverage Initiated at SVB Leerink
07:16am, Friday, 03'rd Apr 2020
Equities research analysts at SVB Leerink assumed coverage on shares of ChemoCentryx (NASDAQ:CCXI) in a note issued to investors on Thursday, TipRanks reports. The brokerage set a “buy” rating and
Credit Suisse AG Has $1.07 Million Stock Holdings in ChemoCentryx Inc (NASDAQ:CCXI)
09:56am, Thursday, 02'nd Apr 2020
Credit Suisse AG grew its holdings in shares of ChemoCentryx Inc (NASDAQ:CCXI) by 53.2% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 27,043 shares of the bi
5 Guru Stocks That Beat the Market
08:52pm, Tuesday, 31'st Mar 2020
Enphase Energy makes the list Continue reading...
5 Guru Stocks That Beat the Market
08:20pm, Tuesday, 31'st Mar 2020
5 Guru Stocks That Beat the Market, Stocks: AXSM,CCXI,DXCM,EIDX,ENPH, release date:Mar 31, 2020
